Search - tctmd.com

Displaying 901 - 920 of 1030

Sort: Relevancy | Date

News Industry News

Medtronic Announces First Implants in Largest-Ever, Global Trial of Cardiac Resynchronization Therapy

August 27, 2014

News Industry News

Medtronic Viva® Cardiac Resynchronization Therapy-Pacemaker Now Available in U.S.

August 25, 2014

News Daily News

Similar Survival Benefits from Surgery, MitraClip in Symptomatic, High-Risk Mitral Regurgitation

L.A. McKeown

August 20, 2014

News Industry News

The Lancet: Remote Monitoring Can Save ICD and CRT-D Patients’ Lives

August 15, 2014

News Industry News

Novartis to showcase heart failure leadership at ESC Congress 2014 with results on new first of its type medicine LCZ696

August 11, 2014

News Daily News

PARTNER Analyses Highlight Mortality Curves After TAVR

Caitlin E. Cox

July 17, 2014

News Daily News

Study of STEMI Care in China Exposes Crucial Treatment Gaps

L.A. McKeown

June 27, 2014

Presentation

Discrepancies in Autologous Bone Marrow Stem Cell Trials and Enhancement of Ejection Fraction

Presenter: A.N. Nowbar

May 13, 2014

News Daily News

Meta-analysis: Bone Marrow Stem Cell Research Riddled with Discrepancies

L.A. McKeown

May 13, 2014

News Industry News

Medtronic Viva® Cardiac Resynchronization Therapy-Pacemaker Now Available in Europe

May 01, 2014

News Industry News

Medtronic CRT Devices Now Approved to Treat Patients with AV Block and Reduced Heart Function

April 10, 2014

News Industry News

CardioKinetix Releases One-Year Clinical Data Showing Consistent, Compelling Positive Results for Patients Treated with Minimally Invasive Structural Heart Device for Heart Failure

April 07, 2014

News Daily News

MADIT-CRT: Resynchronization Ups Survival in Patients with Mild Heart Failure and LBBB

Caitlin E. Cox

April 03, 2014

News Conference News ACC 2014

ACC/i2 2014: Cardiologists Carefully Consider TAVR, Renal Denervation

Yael L. Maxwell

April 03, 2014

News Conference News ACC 2014

Intramyocardial Injection of Stem Cells Shows Promise for Severe Ischemic Heart Failure

Yael L. Maxwell

March 31, 2014

News Conference News ACC 2014

GIPS-III: Diabetes Drug Metformin Not Cardioprotective in Nondiabetic STEMI Patients After Primary PCI

Jason Kahn

March 31, 2014

News Conference News ACC 2014

Massachusetts Study Sees Steep Declines in Revascularization Over Last Decade

L.A. McKeown

March 30, 2014

News Daily News

High Sensitivity Troponin T Assay Shows Strong Prognostic Ability in STEMI Patients

L.A. McKeown

March 20, 2014

News Daily News

Patients with Severe Pulmonary Hypertension Benefit from TAVR Despite Increased Mortality

L.A. McKeown

March 13, 2014

News Daily News

Cell Therapy Fails to Improve on CABG Results

Jason Kahn

February 13, 2014

Advertisement

Medtronic Announces First Implants in Largest-Ever, Global Trial of Cardiac Resynchronization Therapy

Medtronic Viva® Cardiac Resynchronization Therapy-Pacemaker Now Available in U.S.

Similar Survival Benefits from Surgery, MitraClip in Symptomatic, High-Risk Mitral Regurgitation

The Lancet: Remote Monitoring Can Save ICD and CRT-D Patients’ Lives

Novartis to showcase heart failure leadership at ESC Congress 2014 with results on new first of its type medicine LCZ696

PARTNER Analyses Highlight Mortality Curves After TAVR

Study of STEMI Care in China Exposes Crucial Treatment Gaps

Discrepancies in Autologous Bone Marrow Stem Cell Trials and Enhancement of Ejection Fraction

Meta-analysis: Bone Marrow Stem Cell Research Riddled with Discrepancies

Medtronic Viva® Cardiac Resynchronization Therapy-Pacemaker Now Available in Europe

Medtronic CRT Devices Now Approved to Treat Patients with AV Block and Reduced Heart Function

CardioKinetix Releases One-Year Clinical Data Showing Consistent, Compelling Positive Results for Patients Treated with Minimally Invasive Structural Heart Device for Heart Failure

MADIT-CRT: Resynchronization Ups Survival in Patients with Mild Heart Failure and LBBB

ACC/i2 2014: Cardiologists Carefully Consider TAVR, Renal Denervation

Intramyocardial Injection of Stem Cells Shows Promise for Severe Ischemic Heart Failure

GIPS-III: Diabetes Drug Metformin Not Cardioprotective in Nondiabetic STEMI Patients After Primary PCI

Massachusetts Study Sees Steep Declines in Revascularization Over Last Decade

High Sensitivity Troponin T Assay Shows Strong Prognostic Ability in STEMI Patients

Patients with Severe Pulmonary Hypertension Benefit from TAVR Despite Increased Mortality

Cell Therapy Fails to Improve on CABG Results

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content